The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus

Yuan Liu(Synta Pharmaceuticals (United States)), Dan Zhou(Synta Pharmaceuticals (United States))
PLoS ONE
May 14, 2015
Cited by 20


Related Papers